Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

Fig. 1

Boxplots of raw plasma biomarker levels for amyloid PET negative (−) and amyloid PET positive (+) individuals. Statistical analysis was conducted using age and sex adjusted two-way ANOVAs for amyloid PET status and syndrome diagnosis on the plasma biomarker levels, of which the p value of the independent effect of PET status is presented. Plasma GFAP and plasma NfL, levels were natural log transformed prior to statistical analysis. Abeta, amyloid beta; GFAP, glial fibrillary acidic protein; NfL, neurofilament light; PET, positron emission tomography

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193